Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 4Completed 4Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 22Lymphoma, Mantle-Cell 20Lymphoma, Follicular 18Lymphoma 17Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 8Burkitt Lymphoma 8Waldenstrom Macroglobulinemia 7Neoplasms 6Leukemia, Hairy Cell 4Leukemia, B-Cell 3Leukemia 3Hematologic Neoplasms 3beta-Thalassemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Heart Failure 2Epstein-Barr Virus Infections 2Dendritic Cell Sarcoma, Interdigitating 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Anemia, Refractory, with Excess of Blasts 2Thalassemia 1Sjogren's Syndrome 1

Interventions

entrectinib 2atezolizumab 2alectinib 2venetoclax 1pertuzumab 1obinutuzumab 1ibrutinib 1etoposide phosphate 1enzalutamide 1cobimetinib 1capmatinib 1acalabrutinib 1Vincristine 1Vemurafenib 1Trastuzumab 1Specimen Handling 1Rituximab 1Radiotherapy 1Prednisone 1Positron-Emission Tomography 1Nivolumab 1Genetic Testing 1Genetic Counseling 1Follow-Up Studies 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Chromatin Immunoprecipitation Sequencing 1CA-4948 1Biological Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoproliferative Disorders × Rituximab × Clear all
NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Columbia University

Phase 2 Recruiting
30 enrolled
Lymphoid

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡